Provided By PR Newswire
Last update: Jul 17, 2025
NEW YORK, July 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:PETS (10/24/2025, 8:00:00 PM)
2.74
-0.01 (-0.36%)
Find more stocks in the Stock Screener


